A versatile method for encapsulating large-sized DNA into small-sized bioreducible nanocapsules.

J Phys Chem B

CAS Key Lab of Soft Matter Chemistry, Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei 230026, Anhui, People's Republic of China.

Published: April 2014

Encapsulation of negatively charged plasmid DNA into a small-sized nanocapsule without using any condensing agent is very challenging up to now. Here we report a versatile method for encapsulating large-sized plasmid DNAs into small-sized bioreducible nanocapsules in which shearing force and surfactant can fold large-sized plasmid DNAs into small-sized emulsion droplets containing bioreducible branched polymers. Subsequently, temperature triggers the bioreducible branched polymers to aggregate and cross-link at the water/oil interface of the emulsion nanodroplet, forming a bioreducible shell around the nanodroplet. Thus, a small-sized nanocapsule (∼110 nm) containing large-sized plasmid DNA (∼1900 nm long) forms by removal of the surfactant.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jp500683nDOI Listing

Publication Analysis

Top Keywords

large-sized plasmid
12
versatile method
8
method encapsulating
8
encapsulating large-sized
8
dna small-sized
8
small-sized bioreducible
8
bioreducible nanocapsules
8
plasmid dna
8
small-sized nanocapsule
8
plasmid dnas
8

Similar Publications

Nanoplatform-Based In Vivo Gene Delivery Systems for Cancer Therapy.

Small

July 2024

Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.

Gene therapy uses modern molecular biology methods to repair disease-causing genes. As a burgeoning therapeutic, it has been widely applied for cancer therapy. Since 1989, there have been numerous clinical gene therapy cases worldwide.

View Article and Find Full Text PDF

Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection.

ACS Appl Mater Interfaces

January 2024

JST PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan.

RNA and DNA delivery technologies using lipid nanoparticles (LNPs) have advanced significantly, as demonstrated by their successful application in mRNA vaccines. To date, commercially available RNA therapeutics include Onpattro, a 21 bp siRNA, and mRNA vaccines comprising 4300 nucleotides for COVID-19. However, a significant challenge remains in achieving efficient transfection, as the size of the delivered RNA and DNA increases.

View Article and Find Full Text PDF

Conformation-dependent UV inactivation efficiency of a conjugative, multi-drug resistant plasmid.

J Hazard Mater

October 2023

Department of Urban Engineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.

A conjugative, multi-drug-resistant plasmid was irradiated in-vivo and in-vitro with a 265-nm UV-light emitting diode (UV-LED) to investigate the gene inactivation efficiency of a plasmid deoxyribonucleic acid (pDNA) carrying DNA transfer and replication genes. The clinical-isolate 60 kb RP4 plasmid of the IncPα group containing the traG gene, was irradiated intracellularly in E. coli DH5α and extracellularly in a water medium at pH 8.

View Article and Find Full Text PDF

Pathogenic and genomic characterisation of a rabbit sourced Pasteurella multocida serogroup F isolate s4.

BMC Vet Res

July 2022

Institute of Animal Husbandry and Veterinary Medicine, Fujian Academy of Agricultural Sciences, No. 100 Pudang Road, Xindian Town, Jin'an District, Fuzhou, Fujian, 350013, People's Republic of China.

Background: Pasteurella multocida is one of the most significant pathogens for a number of animals. In rabbits, the infection is generally associated with the P. multocida serogroups A and D, and the knowledge about the serogroup F is limited.

View Article and Find Full Text PDF

Site-Directed Mutagenesis Method Mediated by Cas9.

Methods Mol Biol

June 2022

State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Collaborative Innovation Center for Green Transformation of Bio-resources, School of Life Sciences, Hubei University, Wuhan, People's Republic of China.

This study presents an in vitro CRISPR/Cas9-mediated mutagenic (ICM) system that allows rapid construction of designed mutants or site-saturation mutagenesis libraries in a PCR-independent manner. The plasmid DNA is double digested with Cas9 bearing specific single guide RNAs to remove the target nucleotides. Next, T5 exonuclease excises both 5'-ends of the linearized plasmid to generate homologous regions of approximately 15 nt.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!